Show me the honey!

Bioxyne appear on the money with Mymana, they flagged in the quarterly report released 27 July 2018 that

"Revenue
The Company has now resolved production and product registration delays which pushed direct sales revenuesfor Q4 2018 into the next period."

And

"Significant work was undertaken in the quarter ensuring that the product portfolio is appropriately registered in the receiving countries, and on production to enable supply. Inventory costs increased by A$420,000 during the quarter as product was finalised for shipment."

You never commit to inventory costs unless the sales are locked in.

Looking forward to further significant developments this quarter! Especially for China Import Licence for Mymana, BK18 Plus etc etc.

MYMANA is a unique formulation of colostrum, honey and dairy milk formula, sourced from New Zealand and “boosted with vitamins and minerals for sustained energy,” according to Bioxyne.

Imho Mymana looks to be in a great position considering the fin review article today!

• STREET TALK
• Jul 30 2018 at 12:15 AM
• Updated Jul 30 2018 at 12:15 AM

• Save article mce-anchorMy Saved Articles
• Print
• License article

Show me the honey! Chinese giant lobs Manuka bid

• Share via Email
• Share on Google Plus
• Post on facebook wall
• Share on twitter
• Post to Linkedin
• Share on Reddit

https://www.copyright link/content/dam/images/g/r/1/i/t/2/image.related.afrArticleLead.620x350.h139u4.png/1532906991659.jpg
Up-for-sale Manuka Health is a vertically integrated honey producer, collecting honey at the beehive and exporting products to more than 45 countries and 11,000 retail stores. Supplied

• by
• Sarah Thompson
• Anthony Macdonald

The Chinese private equity firm that swooped on Sirtex Medical just months ago has another sweet healthcare deal in its sights.
Street Talk can reveal CDH Investments, which is in the midst of a $7 billion spending spree in the health sector, is among bidders for Pacific Equity Partners' honey-based products maker Manuka Health.
Indicative offers for the business, which is being sold by Luminis Partners, were lodged last Thursday, and included submissions from a range of Chinese parties keen to grab what PEP has marketed as a global healthcare play.
Sources said PEP and Luminis were yet to usher prospective acquirers through to the second round, and would likely draw up a shortlist this week.

However, the emergence of a deep-pocketed Chinese buyer which has shown it's not afraid to swing hard for assets in Australia and across the Tasman - particularly in the health and wellness sector - is expected to be a welcome one.

CDH's $1.9 billion bid for Sirtex in May, pegged at a near 80 per cent premium, was enough for the medical device maker's board to dash the hopes of rival bidder Varian Medical Systems.
Despite the more secure but lower offer of $28 a share from the US trade player, the higher but more complex takeover offer by the Chinese private equity firm of $33.60 was too good to pass up.
CDH also owns a controlling stake in one of New Zealand's biggest vitamins brands, Go Healthy. The business, which operates at the premium end of the market, told The Australian Financial Review in June that with CDH's backing it's aiming to become a top five player in Australia's $3.5 billion vitamins market within two years.
CDH has invested $US5.1 billion in 72 companies across the globe, of which 75 per cent are in consumer products, retailing, services and healthcare sectors. The firm has offices in China, Singapore and Hong Kong and manages $US17 billion in assets.

Its buy-out of Go Healthy in early 2017 was part of a trend across Australasia where Chinese companies looked to snap up brands which were delivering exceptional growth rates as Chinese consumers flocked to the "clean and green" reputations of Australia and New Zealand.
Manuka Health is a vertically integrated honey producer, collecting honey at the beehive and exporting products to more than 45 countries and 11,000 retail stores. Its offerings include functional foods, flavoured Manuka honey, Manuka honey powder, dietary supplements, and wound care and beauty products.
PEP tapped Luminis to prepare Manuka Health for sale in March, as revealed by Street Talk. The private equity buyer acquired the business in 2015 and has since worked with management to grow its sales and earnings.

https://www.copyright link/street-t...chinese-giant-lobs-manuka-bid-20180728-h139u4